About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.97 (+3.85%)
PBM NASDAQ Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. Common Shares share price
PBM price activity
Last Price
$2.970
Change (24hr)
0.11 USD (3.85%)
Volume
32.54K
Volume (4w avg)
-
Open
$2.86
Day Range
$2.70 - $3.00
Previous Close
$2.86
Last Trade
20 Nov, 9:00 pm GMT+0
Delayed
20 Nov, 9:00 pm GMT+0
PBM price performance
Delayed
20 Nov, 9:00 pm GMT+0
PBM details
PBM Market Signals